This image is not available for purchase in your country.

Buparlisib experimental drug molecule

Buparlisib experimental drug molecule

C028/8026

Rights Managed

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

DR TIM EVANS / SCIENCE PHOTO LIBRARY DR TIM EVANS / SCIENCE PHOTO LIBRARY

Caption

Buparlisib. Molecular model of the experimental cancer drug Buparlisib. Buparlisib is a phosphoinositide 3-kinase inhibitor (PI3K inhibitor) undergoing clinical trials for treatment of advanced endocrine-resistant breast cancer. PI3K inhibitors are a class of drugs that function by inhibiting one or more of the phosphoinositide 3-kinase enzymes, which are important in signalling pathways for many cellular functions. These include growth control, metabolism and translation of genes into proteins. Inhibition of any of these processes can result in tumour suppression. Atoms are represented as spheres and are colour-coded: carbon (light blue), hydrogen (white), nitrogen (dark blue), oxygen (red) and iron (green).

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}